- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Uveal Melanoma
Total 10105 results
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Dr. Ronnie ShapiraNot yet recruitingMetastatic Melanoma | Malignant Melanoma | Immunotherapy | Malignant Melanoma Stage IV | BRAF V600E
-
Elizabeth DavisBristol-Myers SquibbTerminatedMetastatic Melanoma | Advanced Melanoma | Metastatic Melanoma Stratified by MHC-II ExpressionUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownStage IV Melanoma | Stage III Melanoma | Amplification | Malignant Skin Melanoma T0France
-
MelanomaPRO, RussiaNovartisRecruitingMelanoma | Melanoma Stage IV | Melanoma Stage IIIRussian Federation
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Eisai Inc.PharmaBio Development Inc.CompletedStage IV Melanoma | Stage IIIC MelanomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbWithdrawnMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
National Cancer Institute (NCI)CompletedSorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma | Melanoma, ExperimentalUnited States
-
Mannkind CorporationTerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
Steinar AamdalTerminatedMetastatic Malignant MelanomaNorway
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedMelanoma | Acral Melanoma | Mucosal Lentiginous MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Universitair Ziekenhuis BrusselRecruiting
-
Assistance Publique - Hôpitaux de ParisSociété de Dermatologie FrançaiseNot yet recruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMelanomaArgentina, United States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Regina Elena Cancer InstituteRecruitingMelanoma (Skin) | Liquid Biopsy | Melanoma Stage IV | Melanoma Stage III | BRAF V600EItaly
-
Universitair Ziekenhuis BrusselRecruitingMelanoma Stage IV | Melanoma Stage IIIBelgium
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
The Netherlands Cancer InstituteRecruiting
-
University of California, San FranciscoArray BioPharmaRecruitingMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Kelly McMastersRecruitingMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
The Netherlands Cancer InstituteAmgenActive, not recruitingMelanoma Stage IV | Melanoma Stage IIINetherlands
-
Universitair Ziekenhuis BrusselCompletedStage IV Melanoma | Stage III MelanomaBelgium
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Acral Malignant MelanomaChina
-
National Cancer Institute (NCI)TerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)CompletedPrecancerous Condition | Stage II Melanoma | Stage 0 Melanoma | Stage I MelanomaUnited States
-
Pierre Fabre MedicamentRecruitingMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical CenterCompletedMucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
Mannkind CorporationCompletedAdvanced Melanoma | Stage III and IV MelanomaUnited States
-
Inge Marie SvaneAdaptimmuneNot yet recruitingMelanoma | Melanoma Stage IV | Melanoma Stage III
-
Taiga Biotechnologies, Inc.RecruitingStage IV Melanoma | Stage III MelanomaUnited States
-
Syntrix Biosystems, Inc.M.D. Anderson Cancer Center; National Cancer Institute (NCI); Massachusetts General... and other collaboratorsRecruitingMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Lisata Therapeutics, Inc.TerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
The Netherlands Cancer InstituteUnknownStage IV Skin Melanoma | Eye; MelanomaNetherlands
-
Medical University of ViennaCompletedStage IV Melanoma | Stage III MelanomaAustria
-
European Organisation for Research and Treatment...Active, not recruitingStage IV Melanoma | Unresectable Stage III MelanomaFrance, Denmark, Spain, Finland, Italy, Germany, Poland, United Kingdom, Netherlands
-
Pierre Fabre MedicamentBiotrialActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Syneos HealthOncolys BioPharma IncUnknownMelanoma Stage Iv | Melanoma Stage IIIUnited States
-
Sheba Medical CenterUnknownMelanoma Stage Iv | Unresectable Stage III MelanomaIsrael
-
iOncturaActive, not recruitingMyelofibrosis | NSCLC | Uveal Melanoma | Solid Tumor, Adult | Non-Hodgkin Lymphoma, AdultUnited Kingdom, Italy
-
Steven BurtonCompletedRecurrent Oligometastatic DiseaseUnited States
-
Mehdi YousefiCompletedRecurrent Implantation FailureIran, Islamic Republic of